Grifols | GRFS - Trade Debtors

Stock Price
8.98
Daily Change
0.02 0.22%
Monthly
-2.29%
Yearly
6.40%
Q1 Forecast
9.14

Grifols reported EUR1.29B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Alaunos Therapeutics USD 2K 0 Jun/2025
aTyr Pharma USD 1.04M 544K Sep/2025
Brainstorm Cell Therapeutics USD 67K 4K Mar/2025
Capricor Therapeutics USD 60K 10.31M Mar/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Grifols EUR 1.29B 83.03M Sep/2025
Immunic USD 1.5M 50K Jun/2024
Nektar Therapeutics USD 0 2.9M Sep/2024
Sangamo BioSciences USD 581K 110K Jun/2024
TherapeuticsMD USD 2.91M 310K Jun/2024